References
- Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859–80.
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314–19.
- Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008;7:525–37.
- Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 2011;115:1248–55.
- Schuele SU, Lüders HO. Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 2008;7:514–24.
- Santos PM. Surgical placement of the vagus nerve stimulator. Operat Tech Otolaryngol Head Neck Surg 2004;15:201–09.
- Berg A, Berkovic S, Brodie M, et al.Revised terminology and concepts for organization of the epilepsies: report of the Commission on Classification and Terminology: International League Against. Epilepsia 2010;51:676–85.
- Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, et al.Vagus Nerve-stimulation for treatment of partial seizures. 1. A controlled-study of effect on seizures. First international vagus nerve stimulation study group. Epilepsia 1994;35:616–26.
- Handforth A, DeGiorgio CM, Schachter SC, et al.Vagus nerve stimulation therapy for partial-onset seizures - a randomized active-control trial. Neurology 1998;51:48–55.
- Lund C, Kostov H, Blomskjøld B, Nakken KO. Efficacy and tolerability of long-term treatment with vagus nerve stimulation in adolescents and adults with refractory epilepsy and learning disabilities. Seizure 2011;20:34–7.
- Ardesch JJ, Buschman HPJ, Wagener-Schimmel L, van der Aa HE, Hageman G. Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study. Seizure 2007;16:579–85.
- Uthman BM, Reichl AM, Dean JC, et al. Effectiveness of vagus nerve stimulation in epilepsy patients - a 12-year observation. Neurology 2004;63:1124–26.
- Elliott RE, Morsi A, Tanweer O, et al. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy Behav 2011;20:478–83.
- Elliott R, Morsi A, Kalhorn SP, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 2011;20:57–63.
- Kuba R, Brazdil M, Kalina M, et al. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure 2009; 18:269–74.
- DeGiorgio CM, Thompson J, Lewis P, et al. Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term XE5 study. Epilepsia 2001;42:1017–20.
- George R, Salinsky M, Kuzniecky R, et al. Vagus nerve-stimulation for the treatment of partial seizures. 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994;35:637–43.
- Morris GL 3rd., Mueller WM. Long-term treatment with vague nerve stimulation in patients with refractory epilepsy. Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999;53:1731–5.
- Vonck K, Boon P, D’Have N, et al. Long-term results of vagus nerve stimulation in refractory epilepsy. Seizure 1999;8:328–34.
- Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. J Pediatr 1999; 134:563–6.
- Helmers SL, Wheless JW, Frost M, et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol 2001;16:843–8.
- Spanaki MV, Allen LS, Mueller WM, Morris GL 3rd. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure 2004;13:587–90.
- Amar AP, Apuzzo MLJ, Liu CY. Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry (Reprinted from Neurosurgery, vol 55, pg 1086–1093, 2004). Neurosurgery 2008; 62:506–13.
- Labar D. Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 2004;13:392–98.